Profil aset
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system. Its product candidates are targeted, receptor-specific therapeutics for the tre…
Terbaru dulu.
Palatin Menyajikan Data Praklinik tentang Agonis MC4R PL2001 di ObesityWeek 2026
Obat dan kandidat lain dari perusahaan yang sama yang dipantau di sektor ini.